Skip to content
303-321-2644
info@denverendocenter.com
799 E. Hampden Ave. Ste 525
Follow My Health Log-In
Home
About Us
Our Staff
Contact
Patient Info
Research Study Opportunities
Cadisegliatin a Adjunctive Therapy in Type 1 Diabetes
Efficacy, Safety, and Tolerability of IMVT 1402 for Graves’ Disease
Eversense Post Approval Study
COVID 19 CONCERNS
Virtual Telemedicine
Schedule Appointment
New Patients
Metabolic and Genetic Endocrine Disorders
Prescription Refills
Pay a Bill
Patient Privacy
Weight Loss Clinic
Weight Loss Clinic FAQ
Follow My Health
Portal Instructions
Resources
Research Study Opportunities
Cadisegliatin a Adjunctive Therapy in Type 1 Diabetes
Efficacy, Safety, and Tolerability of IMVT 1402 for Graves’ Disease
Eversense Post Approval Study
COVID 19 CONCERNS
Home
About Us
Our Staff
Contact
Patient Info
Research Study Opportunities
Cadisegliatin a Adjunctive Therapy in Type 1 Diabetes
Efficacy, Safety, and Tolerability of IMVT 1402 for Graves’ Disease
Eversense Post Approval Study
COVID 19 CONCERNS
Virtual Telemedicine
Schedule Appointment
New Patients
Metabolic and Genetic Endocrine Disorders
Prescription Refills
Pay a Bill
Patient Privacy
Weight Loss Clinic
Weight Loss Clinic FAQ
Follow My Health
Portal Instructions
Resources
Research Study Opportunities
Cadisegliatin a Adjunctive Therapy in Type 1 Diabetes
Efficacy, Safety, and Tolerability of IMVT 1402 for Graves’ Disease
Eversense Post Approval Study
COVID 19 CONCERNS
Patient Info
All of our patient information can be found here. If you have any questions, please
contact our office
for assistance.
COVID 19 Concerns and Procedures
Virtual Telemedicine
New Patients
Follow My Health Portal
Schedule An Appointment
Prescription Refills
Pay A Bill
Patient Privacy
Call Us Today
Scroll to top
